Fast science
Is it time to try or to trial statins to prevent recurrent venous thromboembolism?
Statin use and venous thromboembolism recurrence: a combined nationwide cohort and nested case–control study
Clots and cardiac valve prostheses
Thrombolytic therapy or surgery for valve prosthesis thrombosis: systematic review and meta-analysis
Biosimilars: the process is the product. The example of recombinant streptokinase
Diagnosing type 1 von Willebrand disease: good for patient's health or for doctor's prestige?
Quantitative impact of using different criteria for the laboratory diagnosis of type 1 von Willebrand disease
Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa
Loading dose vs. maintenance dose of warfarin for reinitiation after invasive procedures: a randomized trial
The incidence of venous thromboembolism in commercial airline pilots: a cohort study of 2630 pilots
Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors
A novel F8 −/− rat as a translational model of human hemophilia A
In vivo enrichment of genetically manipulated platelets corrects the murine hemophilic phenotype and induces immune tolerance even using a low multiplicity of infection
The Fc gamma receptor IIa R131H polymorphism is associated with inhibitor development in severe hemophilia A
Predicting dosing advantages of factor VIIa variants with altered tissue factor-dependent and lipid-dependent activities
An evaluation of the potential drug interaction between warfarin and levothyroxine
Reappraisal of the clinical pharmacology of low-dose aspirin by comparing novel direct and traditional indirect biomarkers of drug action
Targeting the anionic region of human protease-activated receptor 4 inhibits platelet aggregation and thrombosis without interfering with hemostasis
Integrin-linked kinase regulates the rate of platelet activation and is essential for the formation of stable thrombi
Plasminogen activator-1 overexpression decreases experimental postthrombotic vein wall fibrosis by a non-vitronectin-dependent mechanism
Phospholipase D is a central regulator of collagen I-induced cytoskeletal rearrangement and podosome formation in megakaryocytes
The risk of venous thromboembolism in renal cell carcinoma patients with residual tumor thrombus: comment
The risk of venous thromboembolism in renal cell carcinoma patients with residual tumor thrombus: reply
Is thrombophilia associated with placenta-mediated pregnancy complications? A prospective cohort study: comment
Is thrombophilia associated with placenta-mediated pregnancy complications? A prospective cohort study: comment
Is thrombophilia associated with placenta-mediated pregnancy complications? A prospective cohort study: reply
Join ISTH